FLUDARABINE-BASED COMBINATION CHEMOTHERAPY IN RELAPSED MANTLE CELL LYMPHOMA - THE EXPERIENCE OF A SINGLE CENTER

被引：0
|
作者：
Moita, F. [1 ]
Santos, J. [1 ]
da Silva, M. G. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0256
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience
    Abbasi, Abdul Muqtadir
    Shaikh, Usman
    Ali, Natasha
    Haider, Mohammad Nadir
    LEUKEMIA RESEARCH REPORTS, 2021, 15
  • [2] Fludarabine, Bortezomib, Myocet® and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma
    Orciuolo, Enrico
    Buda, Gabriele
    Pelosini, Matteo
    Petrini, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (05) : 810 - 812
  • [3] Impairment of peripheral blood stem cell mobilisation in patients with mantle cell lymphoma following primary treatment with fludarabine-based chemotherapy
    Eve, H. E.
    Rule, S. A. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 17 - 18
  • [4] Fludarabine-based reduced intensity conditioning for fanconi anemia - A single center experience
    Even-Or, Ehud
    Cohen, Hodaya
    NaserEddin, Adeeb
    Shadur, Bella
    Avni, Batia
    Grisariu, Sigal
    Zaidman, Irina
    Stepensky, Polina
    BONE MARROW TRANSPLANTATION, 2019, 54 : 218 - 219
  • [5] Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
    Wu, Aaron
    Graf, Solomon A.
    Burwick, Nicholas
    Grim, Jonathan E.
    Dong, Zhao Ming
    Richard, Robert E.
    Chauncey, Thomas R.
    BLOOD RESEARCH, 2020, 55 (01) : 57 - 61
  • [6] Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stent cells for relapsed leukaemia and lymphoma
    Grigg, A
    Bardy, P
    Byron, K
    Seymour, JF
    Szer, J
    BONE MARROW TRANSPLANTATION, 1999, 23 (02) : 107 - 110
  • [7] Delivery and toxicity of fludarabine-based combination chemotherapy regimens in older patients.
    Polizzotto, MN
    Tam, CS
    Januszewicz, H
    Prince, M
    Wolf, M
    Seymour, JF
    BLOOD, 2005, 106 (11) : 930A - 930A
  • [8] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE
    Toprak, S. K.
    Atilla, E.
    Atilla, P. Ataca
    Bozdag, S. Civriz
    Yuksel, M. Kurt
    Topcuoglu, P.
    Demirer, T.
    Arslan, O.
    Ozcan, M.
    Arat, M.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Uysal, A.
    Gurman, G.
    HAEMATOLOGICA, 2017, 102 : 865 - 865
  • [9] MORPHOLOGIC VARIANTS OF MANTLE CELL LYMPHOMA: A RETROSPECTIVE SINGLE CENTER EXPERIENCE
    Paolini, A.
    Forghieri, F.
    Bonacorsi, G.
    Zaldini, P.
    Morselli, M.
    Potenza, L.
    Leonardi, G.
    Riva, G.
    Coluccio, V.
    Bresciani, P.
    Cuoghi, A.
    Maccaferri, M.
    Colaci, E.
    Bigliardi, S.
    Fantuzzi, V.
    Faglioni, L.
    Soci, F.
    Nasillo, V.
    Messerotti, A.
    Pioli, V.
    Arletti, L.
    Lugli, E.
    Gilioli, A.
    Zucchini, P.
    Quadrelli, C.
    Giacobbi, F.
    Corradini, G.
    Marasca, R.
    Narni, F.
    Luppi, M.
    HAEMATOLOGICA, 2015, 100 : 153 - 154
  • [10] Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma
    A Grigg
    P Bardy
    K Byron
    JF Seymour
    J Szer
    Bone Marrow Transplantation, 1999, 23 : 107 - 110
12345